The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.
The GameChangers
The use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration.
Show Segments
00:00 – Introductions
01:56 – Famotidine in the Treatment of COVID-19
10:52 – Effects of Lockdown on COVID-19 Mortality
18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients
23:45 – Closing Remarks
Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Redeem your CPE or CME credit here!
Need a membership?
References and resources:
Continuing Education Information:
Learning Objectives:
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-142-H01-P
Initial release date: 03/28/22
Expiration date: 03/28/2023
Follow CEimpact on Social Media:
LinkedIn
Instagram
Download the CEimpact App for Free Continuing Education + so much more!